Search results
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 4 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Athens commission eases zoning restrictions for expanding research and development enterprises
Athens Banner-Herald via Yahoo News· 6 days agoCommissioners recently allocated nearly $2 million in coronavirus recovery dollars to the Athens...
Alibaba Stock: Buy, Sell, or Hold?
The Motley Fool via AOL· 3 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Beef plant workers in Fresno to lose jobs after Hanford company takes over factory
The Fresno Bee· 4 days agoThe laid-off workers’ last day is Aug. 4.
L.A. County COVID cases, hospitalizations rise amid FLiRT variants summer uptick
Los Angeles Times· 3 days agoLos Angeles County’s COVID cases and hospitalizations are continuing to increase as a new subvariant...
Senior news
Tribune Chronicle· 6 days agoTo include or update items in the weekly Senior News list, email information to tmunnell@tribtoday.com or afox@tribtoday.com. The ...
House GOP opens investigation into bias at media watchdog NewsGuard
The Washington Times· 5 days agoHouse Oversight Chair James Comer announced an investigation Thursday into NewsGuard, an outfit that...
Johnny Boone, the 'Godfather of Grass' and Cornbread Mafia leader, dies
Cincinnati.com | The Enquirer via Yahoo News· 1 day ago"When he was caught and asked his name, he responded, 'Charles Grass.'” Stephanie Kuzydym is an enterprise and investigative reporter. She can be reached at skuzydym@courier-journal.com. Follow ...
Bird flu is rampant in animals. Humans ignore it at our own peril
AccuWeather· 5 days agoDead birds are collected in July 2023 along the coast in the Vadso municipality of Finnmark in...
Alibaba Stock: Buy, Sell, or Hold?
Motley Fool via Yahoo Finance· 3 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...